Chrysin and its emerging role in cancer drug resistance

被引：20
作者：
Kasala, Eshvendar Reddy [1 ]
Bodduluru, Lakshmi Narendra [1 ]
Barua, Chandana C. [2 ]
Gogoi, Ranadeep [3 ]
机构：
[1] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati 781032, Assam, India
[2] Assam Agr Univ, Coll Vet Sci, Dept Pharmacol & Toxicol, Gauhati 781022, Assam, India
[3] Natl Inst Pharmaceut Educ & Res, Dept Biotechnol, Gauhati 781032, Assam, India
来源：
CHEMICO-BIOLOGICAL INTERACTIONS | 2015年 / 236卷
关键词：
Cisplatin; Chrysin; Apoptosis; Cancer therapy; Drug resistance; CELLS; FLAVONOIDS; CISPLATIN;
D O I：
10.1016/j.cbi.2015.04.017
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
This letter illustrates the significant chemosensitizing effects of chrysin to resistance cancer cells and refers to the article on "Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53" by Li et al., published in your journal recently. Recent studies have demonstrated that chrysin is able to sensitize or kill cancer cells which are resistant to chemotherapeutic drugs such as cisplatin, doxorubicin and adriamycin. Owing to its potential anti-cancer effects and devoid of toxicity to non-transformed cells, further research is required to completely explore its chemosensitizing effects in other cancers and also assess and evaluate its safety, before going for possible human application. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
[41]   PfCRT and its role in antimalarial drug resistance [J].
Ecker, Andrea ;
Lehane, Adele M. ;
Clain, Jerome ;
Fidock, David A. .
TRENDS IN PARASITOLOGY, 2012, 28 (11) :504-514
[42]   Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective [J].
Yao, Jiaqi ;
Ma, Chi ;
Feng, Kaixuan ;
Tan, Guang ;
Wen, Qingping .
BIOMOLECULES, 2022, 12 (11)
[43]   Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment [J].
不详 .
MOLECULAR ASPECTS OF MEDICINE, 2025, 104
[44]   Emerging roles of exosomal miRNAs in breast cancer drug resistance [J].
Najminejad, Hamid ;
Kalantar, Seyed Mehdi ;
Abdollahpour-Alitappeh, Meghdad ;
Karimi, Mohammad Hossein ;
Seifalian, Alexander M. ;
Gholipourmalekabadi, Mazaher ;
Sheikhha, Mohammad Hasan .
IUBMB LIFE, 2019, 71 (11) :1672-1684
[45]   Emerging Roles of SKP2 in Cancer Drug Resistance [J].
Wu, Ting ;
Gu, Xinsheng ;
Cui, Hongmei .
CELLS, 2021, 10 (05)
[46]   Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer [J].
Wei, Ling ;
Sun, Jujie ;
Wang, Xingwu ;
Huang, Yizhou ;
Huang, Linying ;
Han, Linyu ;
Zheng, Yanxiu ;
Xu, Yuan ;
Zhang, Nasha ;
Yang, Ming .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
[47]   Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment [J].
Zheng, Long ;
Chang, Ruibai ;
Liang, Bingjing ;
Wang, Yitong ;
Zhu, Yushan ;
Jia, Zijing ;
Fan, Jindian ;
Zhang, Zhe ;
Du, Bo ;
Kong, Dexin .
CANCER DRUG RESISTANCE, 2024, 7
[48]   Role of Jun and Jun kinase in resistance of cancer cells to therapy [J].
Vasilevskaya, I ;
O'Dwyer, PJ .
DRUG RESISTANCE UPDATES, 2003, 6 (03) :147-156
[49]   TGF-β An emerging player in drug resistance [J].
Brunen, Diede ;
Willems, Stefan M. ;
Kellner, Udo ;
Midgley, Rachel ;
Simon, Iris ;
Bernards, Rene .
CELL CYCLE, 2013, 12 (18) :2960-2968
[50]   Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target [J].
Pan, Yinlong ;
Wu, Mengmeng ;
Cai, Huazhong .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
12345